CDK1 and adenocarcinoma: Suppress the proliferative activity in adenoma and adenocarcinoma lesions, without effect on normal colon mucosa, delay cell cycle progression by downregulating cyclin B1 and cdk1 expression via inactivation of NF-κB but did not induce apoptosis